SUN-094 A RANDOMISED CROSS-OVER TRIAL OF THE EFFECTS OF CALCIUM CARBONATE AND SEVELAMER PHOSPHATE BINDERS ON CALCIPROTEIN PARTICLES IN PREVALENT HAEMODIALYSIS PATIENTS Article Swipe
Fumin Pan
,
Edward R. Smith
,
Tim D. Hewitson
,
Benjamin L Wigg
,
Paul J. Champion de Crespigny
,
Nigel D. Toussaint
,
S. Holt
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1016/j.ekir.2020.02.620
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1016/j.ekir.2020.02.620
Conclusions:The mechanisms of damage to the heart and blood vessels in patients with CKD begin to function already in the initial stage of renal failure and increase as it progresses.The need to know the data of clinical, laboratory and instrumental examination methods at the terminal stage of CKD is dictated, first of all, by the possibility of exposure to them.An important stimulus for conducting an echocardiographic examination is the early detection and correction of cardiovascular disorders, in connection with the prospect of increasing the survival of patients after kidney transplantation.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.ekir.2020.02.620
- OA Status
- gold
- Cited By
- 2
- References
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3010932453
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3010932453Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.ekir.2020.02.620Digital Object Identifier
- Title
-
SUN-094 A RANDOMISED CROSS-OVER TRIAL OF THE EFFECTS OF CALCIUM CARBONATE AND SEVELAMER PHOSPHATE BINDERS ON CALCIPROTEIN PARTICLES IN PREVALENT HAEMODIALYSIS PATIENTSWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-03-01Full publication date if available
- Authors
-
Fumin Pan, Edward R. Smith, Tim D. Hewitson, Benjamin L Wigg, Paul J. Champion de Crespigny, Nigel D. Toussaint, S. HoltList of authors in order
- Landing page
-
https://doi.org/10.1016/j.ekir.2020.02.620Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.ekir.2020.02.620Direct OA link when available
- Concepts
-
Sevelamer, Medicine, Phosphate binder, Calcium carbonate, Cross over, Phosphate, Randomized controlled trial, Internal medicine, Calcium, Biochemistry, Chemical engineering, Medical physics, Hyperphosphatemia, Chemistry, EngineeringTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2020: 1Per-year citation counts (last 5 years)
- References (count)
-
1Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3010932453 |
|---|---|
| doi | https://doi.org/10.1016/j.ekir.2020.02.620 |
| ids.doi | https://doi.org/10.1016/j.ekir.2020.02.620 |
| ids.mag | 3010932453 |
| ids.openalex | https://openalex.org/W3010932453 |
| fwci | 0.15693242 |
| type | article |
| title | SUN-094 A RANDOMISED CROSS-OVER TRIAL OF THE EFFECTS OF CALCIUM CARBONATE AND SEVELAMER PHOSPHATE BINDERS ON CALCIPROTEIN PARTICLES IN PREVALENT HAEMODIALYSIS PATIENTS |
| biblio.issue | 3 |
| biblio.volume | 5 |
| biblio.last_page | S240 |
| biblio.first_page | S240 |
| topics[0].id | https://openalex.org/T11280 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9340000152587891 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2720 |
| topics[0].subfield.display_name | Hematology |
| topics[0].display_name | Hemophilia Treatment and Research |
| topics[1].id | https://openalex.org/T11628 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9330000281333923 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2716 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Myeloproliferative Neoplasms: Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T12876 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9218999743461609 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Potassium and Related Disorders |
| is_xpac | False |
| apc_list.value | 3200 |
| apc_list.currency | USD |
| apc_list.value_usd | 3200 |
| apc_paid.value | 3200 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3200 |
| concepts[0].id | https://openalex.org/C2777425297 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9651205539703369 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q904153 |
| concepts[0].display_name | Sevelamer |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.9298972487449646 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2779148903 |
| concepts[2].level | 4 |
| concepts[2].score | 0.645373523235321 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q661790 |
| concepts[2].display_name | Phosphate binder |
| concepts[3].id | https://openalex.org/C2778039128 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5840348601341248 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q23767 |
| concepts[3].display_name | Calcium carbonate |
| concepts[4].id | https://openalex.org/C2993792317 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5705986618995667 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q225458 |
| concepts[4].display_name | Cross over |
| concepts[5].id | https://openalex.org/C2777132085 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5127645134925842 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q46220103 |
| concepts[5].display_name | Phosphate |
| concepts[6].id | https://openalex.org/C168563851 |
| concepts[6].level | 2 |
| concepts[6].score | 0.44852346181869507 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[6].display_name | Randomized controlled trial |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.412663996219635 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C519063684 |
| concepts[8].level | 2 |
| concepts[8].score | 0.3868536949157715 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q706 |
| concepts[8].display_name | Calcium |
| concepts[9].id | https://openalex.org/C55493867 |
| concepts[9].level | 1 |
| concepts[9].score | 0.07637590169906616 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[9].display_name | Biochemistry |
| concepts[10].id | https://openalex.org/C42360764 |
| concepts[10].level | 1 |
| concepts[10].score | 0.07043009996414185 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q83588 |
| concepts[10].display_name | Chemical engineering |
| concepts[11].id | https://openalex.org/C19527891 |
| concepts[11].level | 1 |
| concepts[11].score | 0.049740374088287354 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1120908 |
| concepts[11].display_name | Medical physics |
| concepts[12].id | https://openalex.org/C2776036575 |
| concepts[12].level | 3 |
| concepts[12].score | 0.04640054702758789 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q1641062 |
| concepts[12].display_name | Hyperphosphatemia |
| concepts[13].id | https://openalex.org/C185592680 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[13].display_name | Chemistry |
| concepts[14].id | https://openalex.org/C127413603 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11023 |
| concepts[14].display_name | Engineering |
| keywords[0].id | https://openalex.org/keywords/sevelamer |
| keywords[0].score | 0.9651205539703369 |
| keywords[0].display_name | Sevelamer |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.9298972487449646 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/phosphate-binder |
| keywords[2].score | 0.645373523235321 |
| keywords[2].display_name | Phosphate binder |
| keywords[3].id | https://openalex.org/keywords/calcium-carbonate |
| keywords[3].score | 0.5840348601341248 |
| keywords[3].display_name | Calcium carbonate |
| keywords[4].id | https://openalex.org/keywords/cross-over |
| keywords[4].score | 0.5705986618995667 |
| keywords[4].display_name | Cross over |
| keywords[5].id | https://openalex.org/keywords/phosphate |
| keywords[5].score | 0.5127645134925842 |
| keywords[5].display_name | Phosphate |
| keywords[6].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[6].score | 0.44852346181869507 |
| keywords[6].display_name | Randomized controlled trial |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.412663996219635 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/calcium |
| keywords[8].score | 0.3868536949157715 |
| keywords[8].display_name | Calcium |
| keywords[9].id | https://openalex.org/keywords/biochemistry |
| keywords[9].score | 0.07637590169906616 |
| keywords[9].display_name | Biochemistry |
| keywords[10].id | https://openalex.org/keywords/chemical-engineering |
| keywords[10].score | 0.07043009996414185 |
| keywords[10].display_name | Chemical engineering |
| keywords[11].id | https://openalex.org/keywords/medical-physics |
| keywords[11].score | 0.049740374088287354 |
| keywords[11].display_name | Medical physics |
| keywords[12].id | https://openalex.org/keywords/hyperphosphatemia |
| keywords[12].score | 0.04640054702758789 |
| keywords[12].display_name | Hyperphosphatemia |
| language | en |
| locations[0].id | doi:10.1016/j.ekir.2020.02.620 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2764478277 |
| locations[0].source.issn | 2468-0249 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2468-0249 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Kidney International Reports |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Kidney International Reports |
| locations[0].landing_page_url | https://doi.org/10.1016/j.ekir.2020.02.620 |
| locations[1].id | pmh:oai:jupiter.its.unimelb.edu.au:11343/273814 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306402500 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | Minerva Access (University of Melbourne) |
| locations[1].source.host_organization | https://openalex.org/I165779595 |
| locations[1].source.host_organization_name | University of Melbourne |
| locations[1].source.host_organization_lineage | https://openalex.org/I165779595 |
| locations[1].license | |
| locations[1].pdf_url | http://hdl.handle.net/11343/273814 |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Report |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | http://hdl.handle.net/11343/273814 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5101810216 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5829-6666 |
| authorships[0].author.display_name | Fumin Pan |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | F.F. Pan |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5082628380 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2651-1787 |
| authorships[1].author.display_name | Edward R. Smith |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | E.R. Smith |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5030651775 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-1994-2423 |
| authorships[2].author.display_name | Tim D. Hewitson |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | T.D. Hewitson |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5048125508 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Benjamin L Wigg |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | B. Wigg |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5090482001 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Paul J. Champion de Crespigny |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | P.J. Champion de Crespigny |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5059847889 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-2853-5096 |
| authorships[5].author.display_name | Nigel D. Toussaint |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | N.D. Toussaint |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5027032021 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5004-5539 |
| authorships[6].author.display_name | S. Holt |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | S.G. Holt |
| authorships[6].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.ekir.2020.02.620 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | SUN-094 A RANDOMISED CROSS-OVER TRIAL OF THE EFFECTS OF CALCIUM CARBONATE AND SEVELAMER PHOSPHATE BINDERS ON CALCIPROTEIN PARTICLES IN PREVALENT HAEMODIALYSIS PATIENTS |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11280 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9340000152587891 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2720 |
| primary_topic.subfield.display_name | Hematology |
| primary_topic.display_name | Hemophilia Treatment and Research |
| related_works | https://openalex.org/W2117639138, https://openalex.org/W2161796472, https://openalex.org/W2000512167, https://openalex.org/W2782501828, https://openalex.org/W2045714837, https://openalex.org/W2754428678, https://openalex.org/W2048610595, https://openalex.org/W3181559296, https://openalex.org/W2114892156, https://openalex.org/W3010932453 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2020 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.ekir.2020.02.620 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764478277 |
| best_oa_location.source.issn | 2468-0249 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2468-0249 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Kidney International Reports |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Kidney International Reports |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.ekir.2020.02.620 |
| primary_location.id | doi:10.1016/j.ekir.2020.02.620 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2764478277 |
| primary_location.source.issn | 2468-0249 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2468-0249 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Kidney International Reports |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Kidney International Reports |
| primary_location.landing_page_url | https://doi.org/10.1016/j.ekir.2020.02.620 |
| publication_date | 2020-03-01 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W3010932453 |
| referenced_works_count | 1 |
| abstract_inverted_index.an | 64 |
| abstract_inverted_index.as | 27 |
| abstract_inverted_index.at | 42 |
| abstract_inverted_index.by | 53 |
| abstract_inverted_index.in | 10, 18, 76 |
| abstract_inverted_index.is | 48, 67 |
| abstract_inverted_index.it | 28 |
| abstract_inverted_index.of | 2, 22, 35, 46, 51, 56, 73, 81, 85 |
| abstract_inverted_index.to | 4, 15, 31, 58 |
| abstract_inverted_index.CKD | 13, 47 |
| abstract_inverted_index.and | 7, 25, 38, 71 |
| abstract_inverted_index.for | 62 |
| abstract_inverted_index.the | 5, 19, 33, 43, 54, 68, 79, 83 |
| abstract_inverted_index.all, | 52 |
| abstract_inverted_index.data | 34 |
| abstract_inverted_index.know | 32 |
| abstract_inverted_index.need | 30 |
| abstract_inverted_index.with | 12, 78 |
| abstract_inverted_index.after | 87 |
| abstract_inverted_index.begin | 14 |
| abstract_inverted_index.blood | 8 |
| abstract_inverted_index.early | 69 |
| abstract_inverted_index.first | 50 |
| abstract_inverted_index.heart | 6 |
| abstract_inverted_index.renal | 23 |
| abstract_inverted_index.stage | 21, 45 |
| abstract_inverted_index.damage | 3 |
| abstract_inverted_index.kidney | 88 |
| abstract_inverted_index.already | 17 |
| abstract_inverted_index.failure | 24 |
| abstract_inverted_index.initial | 20 |
| abstract_inverted_index.methods | 41 |
| abstract_inverted_index.them.An | 59 |
| abstract_inverted_index.vessels | 9 |
| abstract_inverted_index.exposure | 57 |
| abstract_inverted_index.function | 16 |
| abstract_inverted_index.increase | 26 |
| abstract_inverted_index.patients | 11, 86 |
| abstract_inverted_index.prospect | 80 |
| abstract_inverted_index.stimulus | 61 |
| abstract_inverted_index.survival | 84 |
| abstract_inverted_index.terminal | 44 |
| abstract_inverted_index.clinical, | 36 |
| abstract_inverted_index.detection | 70 |
| abstract_inverted_index.dictated, | 49 |
| abstract_inverted_index.important | 60 |
| abstract_inverted_index.conducting | 63 |
| abstract_inverted_index.connection | 77 |
| abstract_inverted_index.correction | 72 |
| abstract_inverted_index.disorders, | 75 |
| abstract_inverted_index.increasing | 82 |
| abstract_inverted_index.laboratory | 37 |
| abstract_inverted_index.mechanisms | 1 |
| abstract_inverted_index.examination | 40, 66 |
| abstract_inverted_index.possibility | 55 |
| abstract_inverted_index.instrumental | 39 |
| abstract_inverted_index.cardiovascular | 74 |
| abstract_inverted_index.progresses.The | 29 |
| abstract_inverted_index.Conclusions:The | 0 |
| abstract_inverted_index.transplantation. | 89 |
| abstract_inverted_index.echocardiographic | 65 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 0 |
| institutions_distinct_count | 7 |
| citation_normalized_percentile.value | 0.44915859 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |